StockData
Enveric Biosciences, Inc. logo

Enveric Biosciences, Inc. (ENVB) stock

ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.41−0.03 (-2.08%)

Close on Nov 17, 2026Market cap $6.31MP/E –Yield –

Enveric Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Enveric Biosciences's market cap was $5.86M on Nov 11, 2026, against $2.98M a year earlier. Over the last 5 years it ranged from $895.01K to $78.80B, with a median of $8.72B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$5.86M+211.7%
2025Dec 31, 2025$1.88M-100.0%
2024Dec 31, 2024$8.70B+13.7%
2023Dec 29, 2023$7.66B-34.4%
2022Dec 30, 2022$11.67B-85.2%
2021Dec 31, 2021$78.80B+243.7%
2020Dec 31, 2020$22.93B-62.6%
2019Dec 31, 2019$61.33B+42.2%
2018Dec 31, 2018$43.12B-91.9%
2017Dec 29, 2017$530.87B-44.0%
2016Dec 30, 2016$948.10B+14.3%
2015Dec 31, 2015$829.61B–

More Enveric Biosciences figures

See a number that looks wrong?